| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.54B | 50.78B | 49.91B | 47.40B | 44.09B | 43.87B |
| Gross Profit | 34.62B | 33.52B | 32.91B | 31.58B | 29.52B | 29.07B |
| EBITDA | 2.37B | 2.43B | 2.93B | 1.63B | 382.00M | 607.00M |
| Net Income | 455.00M | 888.00M | 1.69B | 502.00M | -1.11B | -38.00M |
Balance Sheet | ||||||
| Total Assets | 43.17B | 42.98B | 40.02B | 37.37B | 35.78B | 39.93B |
| Cash, Cash Equivalents and Short-Term Investments | 13.26B | 13.61B | 13.76B | 12.86B | 11.95B | 15.66B |
| Total Debt | 1.91B | 1.95B | 1.79B | 2.02B | 2.17B | 5.26B |
| Total Liabilities | 10.56B | 10.21B | 9.99B | 9.16B | 8.34B | 10.94B |
| Stockholders Equity | 32.07B | 32.24B | 29.49B | 27.75B | 27.07B | 28.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -454.00M | 1.23B | 990.00M | -95.00M | -218.00M |
| Operating Cash Flow | 0.00 | 1.26B | 2.71B | 2.61B | 1.51B | 1.58B |
| Investing Cash Flow | 0.00 | -178.00M | -2.21B | -1.78B | 330.00M | -803.00M |
| Financing Cash Flow | 0.00 | -534.00M | -479.00M | -487.00M | -3.52B | -345.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥7.71B | -522.29 | ― | 2.05% | 13.52% | -42.59% | |
66 Neutral | ¥22.28B | 10.52 | ― | 3.53% | -2.73% | -51.48% | |
65 Neutral | ¥40.35B | 9.40 | ― | 2.19% | 17.90% | 14.14% | |
64 Neutral | ¥30.40B | 26.96 | ― | 1.38% | 0.03% | 6.01% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥24.47B | 3.19 | ― | 0.95% | 4.14% | ― | |
58 Neutral | ¥5.43B | 176.28 | ― | ― | 3.98% | ― |